KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $356,000 | -53.8% | 1,978 | -74.0% | 0.00% | -50.0% |
Q2 2017 | $771,000 | +190.9% | 7,619 | +98.2% | 0.00% | +300.0% |
Q1 2017 | $265,000 | -58.1% | 3,844 | -73.9% | 0.00% | -75.0% |
Q4 2016 | $632,000 | -37.1% | 14,707 | -21.7% | 0.00% | -33.3% |
Q3 2016 | $1,004,000 | -0.7% | 18,793 | -7.0% | 0.01% | -14.3% |
Q2 2016 | $1,011,000 | +21.1% | 20,215 | +11.2% | 0.01% | 0.0% |
Q1 2016 | $835,000 | -7.6% | 18,185 | +23.9% | 0.01% | 0.0% |
Q4 2015 | $904,000 | +4.4% | 14,675 | -5.7% | 0.01% | -12.5% |
Q3 2015 | $866,000 | +4.0% | 15,560 | +13.9% | 0.01% | 0.0% |
Q2 2015 | $833,000 | – | 13,658 | +2176.3% | 0.01% | – |
Q1 2015 | $0 | -100.0% | 600 | -97.8% | 0.00% | -100.0% |
Q4 2014 | $1,562,000 | – | 27,080 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|